Title
Molecular docking analysis of protein filamin-A with thioazo compounds
Authors
Sudarshan Satish1, Gayathri Rengasamy*1, Surya Sekaran2, Kavitha Sankaran, Vishnu Priya Veeraraghavan1 & Rajalakshmanan Eswaramoorthy*2
Affiliation
1Department of Biochemistry, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai-600077; 2Department of Biomaterials (Green lab), Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Science (SIMATS), Saveetha University, Chennai-600077; *Corresponding author
Sudarshan Satish – E-mail: 152101010.sdc@saveetha.com
Gayathri Rengasamy - E-mail: gayathri.sdc@saveetha.com
Surya Sekaran - E-mail: suryas.sdc@saveetha.com
Kavitha Sankaran - E-mail: kavithas.sdc@saveetha.com
Vishnu Priya Veeraraghavan - E-mail: vishnupriya@saveetha.com
Rajalakshmanan Eswaramoorthy - E-mail: rajalakshmanane.sdc@saveetha.com
Article Type
Research Article
Date
Received January 1, 2023; Revised January 30, 2023; Accepted January 31, 2023, Published January 31, 2023
Abstract
It is of interest to document the molecular docking analysis of protein Filamin-A with thioazo compounds. The compounds 1, 3, 5, and 6 showed best molecular docking interaction as compared to the drug doxorubicin. Among the selected ligands (1-6), compound 3 shows better interaction score than doxorubicin and follows Lipinski's rule of five. Hence, it could be considered as a potential lead molecule for inhibiting protein filamin A in the treatment of oral cancer.
Keywords
Oral cancer, thio azo derivatives, protein filamin-a, drug discovery
Citation
Satish et al. Bioinformation 19(1): 99-104 (2023)
Edited by
P Kangueane
ISSN
0973-2063
Publisher
License
This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.
